Emzor Pharmaceutical Industries Ltd, under the leadership of Dr. Stella Okoli, is poised to revolutionize Nigeria’s pharmaceutical landscape with the launch of a ₦35 billion API manufacturing facility in Sagamu, Ogun State. This monumental project is designed to enhance local drug production, reduce dependency on imports, and address critical health challenges such as malaria.
Established in 1984, Emzor has evolved from a modest retail pharmacy into a leading pharmaceutical company in Nigeria, offering over 140 high-quality products. The new API plant, sprawling over 60 hectares, is a testament to Emzor’s commitment to innovation and healthcare excellence……CONTINUE READING
Emzor has collaborated with India’s Mangalam Drugs and Organics Limited for technology transfer, training, and initial production processes. Additionally, the European Investment Bank has extended a €14 million loan to support the establishment of this facility.
The API plant is expected to significantly lower the cost of essential medicines, improve accessibility, and ensure the availability of high-quality drugs. By producing APIs locally, Nigeria can mitigate the risks associated with importation delays and currency fluctuations.
Dr. Stella Okoli’s visionary leadership continues to shape Nigeria’s pharmaceutical industry. The new API facility not only underscores Emzor’s dedication to healthcare advancement but also positions Nigeria as a key player in pharmaceutical manufacturing within Africa.
